Ukraine may cancel marketing authorizations for pharmaceuticals held by companies with ties to pharmaceutical manufacturing in Russia or Belarus

Baker McKenzie’s Sanctions Blog published the alert titled Ukraine may cancel marketing authorizations for pharmaceuticals held by companies with ties to pharmaceutical manufacturing in Russia or Belarus on 9 May 2022. Read the article via the link here. Please also visit our Sanctions Blog for the most recent updates.